Discover what's new.

Access the latest news, business developments, company updates, industry trends, events and more.

| By Bill Kelly

Yale professor receives CASE science medal

The Connecticut Academy of Science and Engineering has announced that Yale School of Medicine professor Pasko Rakic is the 2019 recipient of the Connecticut Medal...

| By Bill Kelly

Hartford partners to launch medtech accelerator

Hartford HealthCare, Trinity College and the UConn School of Business are planning the launch a medical technology and digital health accelerator, which would join insurance...

| By Bill Kelly

BioXcel Therapeutics blooms in New Haven

Twelve stories above New Haven Harbor, BioXcel Therapeutics is using Big Data technology to mine Big Pharma chemistry and create new drugs that treat pancreatic cancer...

| By Bill Kelly

UConn spearheads animal vaccine, ADHD research

The U.S. Department of Agriculture National Institute of Food and Agriculture has designated UConn’s CEVR (Center of Excellence for Vaccine Research) to be the National Center...

| By Bill Kelly

Intensity gets FDA Fast Track for breast cancer drug

Intensity Therapeutics has received an FDA Fast Track designation for its INT230-6 for the treatment of patients with relapsed or metastatic triple negative breast cancer (TNBC)...

| By Bill Kelly

Arvinas protein degrader therapeutic hits clinic

New therapeutics that harness cellular machinery to degrade targets are entering clinical trials, led by a PROTAC anticancer candidate developed by Arvinas. Whereas most small...

| By Bill Kelly

Achillion reports enrollments in two trials

Achillion reports that it achieved threshold enrollment in the Phase 2 trials of ACH-4471 for patients with C3 glomerulopathy (C3G), a devastating disease affecting the...

| By Bill Kelly

Branford-based ViiV’s Dovato wins FDA approval

GSK’s ViiV secured FDA approval for Dovato after submitting a marketing application with a priority review voucher (PRV) last October. The drug is used to treat...

| By Bill Kelly

UConn teams up to create stem cell biobank

A new collaboration between UConn Health and the Foundation for Prader-Willi Research will create a centralized, high quality biobank of stem cells to help researchers...